The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

Researchers found that mindfulness meditation can modify how a person experiences pain in a way that uses no drugs, proving ...